Slides Available from Public Meeting on Unmet Need for New Therapies to Treat OA

A public meeting to discuss the unmet need for new therapies to treat OA was held on May 16, 2019 in Washington with 80 people attending in person or via webex.  The speaker slides are now available. See link below. 

The Pre-Competitive Consortium for OA (PCCOA) was created by OARSI more than a decade ago in response to a Federal Register Notice seeking a critical appraisal on a number of questions that would help to inform the updating of the 1999 guidance for Clinical Development Programs for the Treatment and Prevention OA.  Subsequently in 2016, OARSI submitted a White Paper to the FDA providing a comprehensive review and rationale for OA to be defined as a potentially serious disease...

 

 

Call for Papers for a Special Theme Issue on The Innate Immune System: Its role in OA pathogenesis, progression, and therapy

The editors of the journal Osteoarthritis and Cartilage announce a request for original research papers for a special themed issue addressing “Innate Immunity in OA”. 

 

Osteoarthritis and Cartilage Open: A NEW OARSI Open access Journal

Based on its vision to be the preeminent voice and expert resource in OA research and its application worldwide through a thriving international network of passionate, purpose-driven and progressive leadership, the Osteoarthritis Research Society recognized the need to establish Osteoarthritis and Cartilage Open, a new scientific open access journal that would publish multidisciplinary findings from the clinical and basic sciences in all fields of research of relevance to osteoarthritis, cartilage, and intervertebral disc in the form of original articles, reviews and hypotheses. Osteoarthritis and Cartilage Open will also accept experimental and clinical study protocols and manuscripts describing the large data sets obtained from experimental or clinical studies.We at...

Learn More about OARSI

Photo Gallery

Spread the Word